How can benign tumors cause clinical problems? A. There is potential for metastasis B. They contain specialized cells that generate adenocarcinomas C. They have a direct connection to the nervous system D. They release dangerously high levels of hormones that create E. physiologic imbalances in the body

How can benign tumors cause clinical problems? A. There is potential for metastasis B. They contain specialized cells that generate adenocarcinomas C. They have a direct connection to the nervous system D. They release dangerously high levels of hormones that create E. physiologic imbalances in the body

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

ChapterCRE2: Comprehensive Review Exam For Part 2

Section: Chapter Questions

Problem 11CEP2

See similar textbooks

Similar questions

1. Differentiate leukemia from lymphoma and myeloma as to: a. hallmark cells / blood features b. organ in the body affected 2. In the 6 factors related to the occurrence of leukemia, rank them in order in which you think is the most related (1 for most related, 6 for least related). Give the reason for your ranking. 3. Rationalize why most leukemic patient die of infection. 4. In patients with leukemia, there is fatigue, weight loss, easy bruisability. Why do you think this is so?
2. An 82-year-old male is admitted to the hospital with a chief complaint of a constant, dull back pain. Labora- tory tests are conducted and show an elevated alkaline phosphatase level. The patient spends several weeks in the hospital and he dies several weeks later. An autopsy shows his vertebra contain nodular lesions. What is the probable diagnosis? a. b. Where is the primary site for the pathology? What are the common cancers that metastasize to the bone? С.
Describe and differentiate among three examples ofmalignant tumors: skin cancer, ovarian cancer, and braincancer.
Explain the systemic effects of malignant tumors with regard to (1) pain, (2) bleeding, (3) weight loss, (4) and fatigue
1:e 66 of 145 88. A 57-year-old woman with a long history of chronic hepatitis B infection has the recent development of an avascular hepatocellular carcinoma. A CT scan is shown in which the tumor indicated by the arrows does not contain any contrast medium whereas the remainder of the liver does. Into which of the following arteries was the contrast medium most likely injected? OA) Femoral B) Gastroduodenal OC) Left hepatic Gross Anatomy D) Proper hepatic OE) Superior mesenteric
explain how do the CIN MSI CIMP pathways all link together in develpment of adenocarcinoma tumours colorectal cancer. Give full explanation if there do or do not link.
5. Imatinib, a tyrosine kinase inhibitor, has revolutionized the treatment of chronic myelogenous leukemia (CML). Explain 1) why individuals with CML respond well to imatinib, 2) the mechanism of action of imatinib, and 3) the impact of imatinib on CML outcome/survival.
b. Individuals with these cancers may be treated with one of the following chemotherapeutic drugs. Complete the table below about their mechanisms of action. , Which process is targeted first by this drug? In which cellular compartment/ structure/organelle does this process occur? Drug Drug's mechanism of action If more than 1 location, be sure to specify ALL relevant locations. (replication, mitosis, transcription, translation, or none of the above)? A Inhibits microtubule disassembly В Inhibits elongation by RNA polymerase Inhibits eukaryotic ribosomal function
b. Individuals with these cancers may be treated with one of the following chemotherapeutic drugs. Complete the table below about their mechanisms of action. Which process is targeted first by this drug? In which cellular compartment/ structure/organelle does this process occur? Drug Drug's mechanism of action (replication, mitosis, transcription, translation, or none of the above)? If more than 1 location, be sure to specify ALL relevant locations. A Inhibits microtubule disassembly Inhibits elongation by RNA polymerase B Inhibits eukaryotic ribosomal function
Describe how tumors can grow to large sizes and alsospread to other parts of the body.
4. Indicate the hallmark / characteristics features in: a. CLL b. CML c. AML d. ALL 5. In hairy cell leukemias (HCL), tartrate resistant acid phosphatase is demonstrated. In your opinion, is this the most reliable test to diagnose HCL at present. Explain in not more than 3 sentences. 6. The use of monoclonal antibodies to detect cluster of differentiation (CD) in leukemic cells, mostly immature cells is common in the laboratory. Why do you think this is more valuable than morphological examination of cells in the blood/bone marrow cells. 7. Differentiate Hodgkin Lymphoma from Non-Hodgkin Lymphoma as to the life expectancy of the patients and degree of malignancy. 8. Compare polycythemia vera from essential thrombocythemia as to laboratory profile
Describe the features that distinguish benign from malignant tumours, explaining the clinical importance of this distinction.